Search

Search articles for

Advanced filters

Published AfterYearMonthDay

Published BeforeYearMonthDay

By Author

By Section

By Issue

Search Results

##search.searchResults.foundPlural##

S-MAPA: bridging the gap in psoriasis severity assessment

Trang Thi Thuy Vu, Chuyen Thi Hong Nguyen, Trung The Van

28-05-2025

https://doi.org/10.4081/dr.2025.10231

621

PDF: 282

HTML: 15
Efficacy of tildrakizumab 200 mg for treating difficult-to-treat patient populations with moderate-to-severe plaque psoriasis

Paolo Dapavo, Matteo Megna, Marina Talamonti

09-08-2024

https://doi.org/10.4081/dr.2024.9999

1739

PDF: 669

HTML: 94
Intra-class switch among interleukin-17 inhibitors for the treatment of plaque psoriasis: a single-center experience

Gioele Ghezzi, Luciano Ibba, Luigi Gargiulo, Alessandra Narcisi, Antonio Costanzo, Mario Valenti

12-11-2024

https://doi.org/10.4081/dr.2024.10080

1172

PDF: 659

HTML: 27
Real-world treatment patterns, patient-reported outcomes, and effectiveness of flexible-dosing etanercept in patients with plaque psoriasis in Greece

Dimitris Rigopoulos, Aikaterini Patsatsi, Christina Antoniou, Dimitrios Sotiriadis, Angeliki Roussaki-Schulze, Nadia Boubouchairopoulou, Ioannis Skiadas, Vasillios Tsekouras, Ana Cristina Hernandez Daly

21-11-2022

https://doi.org/10.4081/dr.2022.9265

1531

PDF: 450

HTML: 27
Cost analysis in the management of moderate-to-severe psoriasis: comparison between conventional and biological systemic therapies

Edoardo Mortato, Silvia Baratta, Luca Rubino, Anna Paola De Caro, Francesco Loconsole

19-06-2023

https://doi.org/10.4081/dr.2023.9755

851

PDF: 415

HTML: 17
Anti-interleukin-17 and anti-interleukin-23 biologic drugs for genital psoriasis: a single-center retrospective comparative study

Andrea Cortese, Luigi Gargiulo, Luciano Ibba, Giovanni Fiorillo, Francesco Toso, Carlo Alberto Vignoli, Alessandra Narcisi, Antonio Costanzo, Mario Valenti

19-05-2023

https://doi.org/10.4081/dr.2023.9692

1057

PDF: 546

HTML: 19
Real-world use of dimethyl fumarate in patients with plaque psoriasis: a Delphi-based expert consensus

Martina Burlando, Elena Campione, Aldo Cuccia, Giovanna Malara, Luigi Naldi, Francesca Prignano, Leonardo Zichichi

29-12-2022

https://doi.org/10.4081/dr.2023.9613

1777

PDF: 519

HTML: 75
Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as inflammatory markers in psoriasis: a case-control study

Hao Trong Nguyen, Long Dinh Hoang Vo, Nguyen Nhat Pham

14-07-2022

https://doi.org/10.4081/dr.2022.9516

1640

PDF: 720

HTML: 21
Efficacy and safety of adalimumab biosimilar GP2017 in a 24-month treatment period for plaque psoriasis: real-life experience from Emilia-Romagna centers, Italy

Marco May Lee, Vito Di Lernia, Francesca Peccerillo, Federico Bardazzi, Michela Tabanelli, Michela Ricci, Davide Melandri, Monica Corazza, Francesca Satolli, Andrea Conti

01-07-2025

https://doi.org/10.4081/dr.2025.10315

536

PDF: 262

HTML: 13
Increased serum interleukin-31 levels correlate with pruritus in psoriatic patients: a cross-sectional study in Vietnam

Chuyen Thi Hong Nguyen, Liem Viet Quoc Tran

27-11-2024

https://doi.org/10.4081/dr.2024.10090

746

PDF: 366

HTML: 27
Tildrakizumab in the treatment of plaque psoriasis in an HIV+ patient: a case report and literature review of anti-interleukin drugs

Viviana Lora, Dario Graceffa, Monia Di Prete, Carlo Cota

11-11-2024

https://doi.org/10.4081/dr.2024.10140

989

PDF: 521

SUPPLEMENTARY MATERIAL: 153

HTML: 16
Increased plasma lipocalin-2 levels correlate with disease severity and may be a marker of acute inflammatory response in patients with psoriasis

Chuyen Thi Hong Nguyen, Oanh Phan Tram Nguyen

21-11-2022

https://doi.org/10.4081/dr.2022.9469

1306

PDF: 548

HTML: 34
A study on tumor necrosis factor-α single nucleotide polymorphisms and psoriasis vulgaris in Vietnam

Vinh Ngo Minh, Thiên Phúc Lý, Hao Nguyen Trong, Chuong Nguyen Hoang

12-04-2024

https://doi.org/10.4081/dr.2024.9899

965

PDF: 564

HTML: 25
HLA-Cw6 increases the risk of psoriasis and early onset before twenty-seven years of age among the Vietnamese population

Nhi Thi Uyen Pham, Thuong Van Nguyen, Hao Trong Nguyen

16-10-2023

https://doi.org/10.4081/dr.2023.9854

1289

PDF: 527

HTML: 27
The suitability of mesenchymal stem cells for treating immune-mediated inflammatory skin diseases: a systematic review

Elena Pezzolo, Sara Di Leo, Paola Miceli, Alvise Sernicola, Luigi Naldi

01-07-2025

https://doi.org/10.4081/dr.2025.10112

767

PDF: 555

HTML: 20
Severe relapse of generalized psoriasis in a young patient with a Löfgren syndrome history

Ermira Ziçishti, Migena Vargu, Sabina Dedej, Eriselda Kurushi, Valbona Zenelaj, Ermira Vasili

13-03-2025

https://doi.org/10.4081/dr.2025.10021

441

PDF: 304

HTML: 7
Mycobacterium kansasii infection in a psoriasis patient treated with adalimumab and switch to apremilast: First report and literature review

Alexandra Maria Giovanna Brunasso, Sanja Javor, Emanuele Pontali, Simona Sola, Cesare Massone

29-07-2021

https://doi.org/10.4081/dr.2021.8797

3060

PDF: 647

HTML: 10
Guselkumab for the treatment of severe plaque psoriasis in a schizophrenia patient

Nicoletta Bernardini, Nevena Skroza, Elisabeth Prevete, Federica Marraffa, Ilaria Proietti, Ersilia Tolino, Alessandra Mambrin, Giovanni Rossi, Salvatore Volpe, Giuseppe Bersani, Concetta Potenza

23-11-2022

https://doi.org/10.4081/dr.2022.9476

1359

PDF: 491

HTML: 26
Seven cancer patients receiving guselkumab for treatment of moderate-to-severe psoriasis

Luca Mastorino, Niccolò Siliquini, Gianluca Avallone, Michela Ortoncelli, Pietro Quaglino, Paolo Dapavo, Simone Ribero

17-03-2022

https://doi.org/10.4081/dr.2022.9282

1162

PDF: 825

HTML: 41
Long term efficacy, safety, and tolerability of tildrakizumab in epileptic patient with psoriasis and eczema

Nicoletta Bernardini, Nevena Skroza, Giovanni Rossi, Alessandra Mambrin, Ersilia Tolino, Federica Marraffa, Martina Caviglia, Antonio Di Guardo, Salvatore Volpe, Ilaria Proietti, Concetta Potenza

21-11-2022

https://doi.org/10.4081/dr.2022.9447

1306

PDF: 405

HTML: 45
Lentiginous eruption in resolving psoriasis plaques during treatment with ixekizumab: a case report and review of the literature

Pablo Santa María, Fernando Valenzuela, Claudia Morales, Raul De la Fuente, Roberto Cullen

11-10-2017

https://doi.org/10.4081/dr.2017.7079

1377

PDF: 661

HTML: 142
Exacerbation of generalized plaque psoriasis after tuberculin test

Alberto Corrà, Lavinia Quintarelli, Alice Verdelli, Walter Volpi, Marzia Caproni

28-07-2021

https://doi.org/10.4081/dr.2021.9019

3189

PDF: 503

HTML: 227
Dimethyl fumarate as a safe and effective therapy for recalcitrant psoriasis in comorbid patients

Martina Burlando, Mattia Fabio Molle, Emanuele Cozzani, Aurora Parodi

14-03-2022

https://doi.org/10.4081/dr.2022.9091

2625

PDF: 632

HTML: 6
Skin tissue expression and serum level of thymic stromal lymphopoietin in patients with psoriasis vulgaris

Oki Suwarsa, Hartati Purbo Dharmadji, Endang Sutedja, Lengga Herlina, Putri Reno Sori, Reti Hindritiani, Reiva Farah Dwiyana, Hendra Gunawan

20-06-2019

https://doi.org/10.4081/dr.2019.8006

1549

PDF: 730

HTML: 48
Erythrodermic psoriasis improved by tildrakizumab

Giampaolo Trevisan, Lerica Germi, Luigi Naldi

23-11-2022

https://doi.org/10.4081/dr.2022.9448

1139

PDF: 620

HTML: 21

1 - 25 of 36 items 1 2 > >>

Search

Search Results

S-MAPA: bridging the gap in psoriasis severity assessment

Efficacy of tildrakizumab 200 mg for treating difficult-to-treat patient populations with moderate-to-severe plaque psoriasis

Intra-class switch among interleukin-17 inhibitors for the treatment of plaque psoriasis: a single-center experience

Real-world treatment patterns, patient-reported outcomes, and effectiveness of flexible-dosing etanercept in patients with plaque psoriasis in Greece

Cost analysis in the management of moderate-to-severe psoriasis: comparison between conventional and biological systemic therapies

Anti-interleukin-17 and anti-interleukin-23 biologic drugs for genital psoriasis: a single-center retrospective comparative study

Real-world use of dimethyl fumarate in patients with plaque psoriasis: a Delphi-based expert consensus

Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as inflammatory markers in psoriasis: a case-control study

Efficacy and safety of adalimumab biosimilar GP2017 in a 24-month treatment period for plaque psoriasis: real-life experience from Emilia-Romagna centers, Italy

Increased serum interleukin-31 levels correlate with pruritus in psoriatic patients: a cross-sectional study in Vietnam

Tildrakizumab in the treatment of plaque psoriasis in an HIV+ patient: a case report and literature review of anti-interleukin drugs

Increased plasma lipocalin-2 levels correlate with disease severity and may be a marker of acute inflammatory response in patients with psoriasis

A study on tumor necrosis factor-α single nucleotide polymorphisms and psoriasis vulgaris in Vietnam

HLA-Cw6 increases the risk of psoriasis and early onset before twenty-seven years of age among the Vietnamese population

The suitability of mesenchymal stem cells for treating immune-mediated inflammatory skin diseases: a systematic review

Severe relapse of generalized psoriasis in a young patient with a Löfgren syndrome history

Mycobacterium kansasii infection in a psoriasis patient treated with adalimumab and switch to apremilast: First report and literature review

Guselkumab for the treatment of severe plaque psoriasis in a schizophrenia patient

Seven cancer patients receiving guselkumab for treatment of moderate-to-severe psoriasis

Long term efficacy, safety, and tolerability of tildrakizumab in epileptic patient with psoriasis and eczema

Lentiginous eruption in resolving psoriasis plaques during treatment with ixekizumab: a case report and review of the literature

Exacerbation of generalized plaque psoriasis after tuberculin test

Dimethyl fumarate as a safe and effective therapy for recalcitrant psoriasis in comorbid patients

Skin tissue expression and serum level of thymic stromal lymphopoietin in patients with psoriasis vulgaris

Erythrodermic psoriasis improved by tildrakizumab

authors

reviewers

Categories

indexing

dermatopathology